Avantor, Inc. (AVTR) Stock
AVTR Key Statistics
About Avantor, Inc.
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
CEO: Emmanuel Ligner. Company website
AVTR — Frequently Asked Questions
What is the AVTR stock price today?
Avantor, Inc. (AVTR) trades at $15.73, up 1.03% on the day, as of Nov 12, 2026 09:30 UTC.
What is Avantor, Inc.'s market cap?
Avantor, Inc. has a market capitalisation of $10.66B, calculated from the live AVTR share price and shares outstanding.
What is the P/E ratio of AVTR?
AVTR trades at a trailing P/E of 31.62, from earnings per share of $0.50 over the last twelve months.
How much revenue does Avantor, Inc. make?
Avantor, Inc. generated revenue of $6.64B over the trailing twelve months, which puts the stock at 1.61 times sales.
What is the 52-week range for AVTR?
AVTR has traded between $7.27 and $17.45 over the past 52 weeks, and the last price is 9.9% below that high.
Is Avantor, Inc. profitable?
Yes. Avantor, Inc. keeps 5.08% of revenue as net income over the trailing twelve months.
What is the analyst price target for AVTR?
Wall Street analysts rate AVTR Hold, with an average price target of $14.55, 7.5% below the current price.
What sector is Avantor, Inc. in?
Avantor, Inc. is classified under the Healthcare sector and the Medical - Instruments & Supplies industry, and is domiciled in US.
Who is the CEO of Avantor, Inc.?
Emmanuel Ligner is the chief executive of Avantor, Inc., which employs 13,500 people.
Where can I track AVTR in real time?
QFI Terminal shows AVTR with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See AVTR live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open AVTR in Terminal See plans